Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI and machine learning analytics
Total raised: $14.68M
Investors 2
| Date | Name | Website |
| 03.04.2024 | Molten Ven... | moltenvent... |
| - | COREangels... | coreangels... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.01.2024 | Series A | $14.68M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 24.01.2024 | IMU Biosciences Raises £11.5M in Series A Funding | IMU Biosciences, a London, UK-based techbio company working in the field of the immune powered preci... | finsmes.co... |
| 24.01.2024 | IMU Biosciences secures £11.5 million in Series A funding to... | - | globenewsw... |
| - | IMU Biosciences | “Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a... | fastfounde... |